1. Home
  2. RNAZ vs XELB Comparison

RNAZ vs XELB Comparison

Compare RNAZ & XELB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

HOLD

Current Price

$8.73

Market Cap

8.3M

Sector

Health Care

ML Signal

HOLD

Logo Xcel Brands Inc.

XELB

Xcel Brands Inc.

HOLD

Current Price

$1.25

Market Cap

8.4M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNAZ
XELB
Founded
2016
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Multi-Sector Companies
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
8.3M
8.4M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
RNAZ
XELB
Price
$8.73
$1.25
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
26.9K
75.6K
Earning Date
04-15-2026
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
48.37
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$102.11
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.82
$0.74
52 Week High
$20.99
$2.66

Technical Indicators

Market Signals
Indicator
RNAZ
XELB
Relative Strength Index (RSI) 61.39 35.91
Support Level $8.38 $1.25
Resistance Level $9.93 $1.62
Average True Range (ATR) 1.21 0.16
MACD 0.09 -0.03
Stochastic Oscillator 66.97 10.00

Price Performance

Historical Comparison
RNAZ
XELB

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

Share on Social Networks: